It’s a marvel that has bewildered researchers since the 1970s. Looking at the size of elephant, they ought to have a substantially higher rate of the sickness. The bigger a living thing, the more the cells, and the more the cells, the more possibility one of them ends up being carcinogenic―which is the reason tall individuals are more helpless against the sickness than short individuals and why Marmaduke is considerably more liable for causing cancer than the Taco Bell Chihuahua. But, growth rate among elephants is under 5%, practically identical to the rates in significantly smaller creatures. The lifetime tumor death rate for people is around 20%.
On Tuesday, in a paper distributed in the Cell Reports journal, scientists from the University of Chicago declared they may have found one of the mechanisms for cancer protection the pachyderms have developed to manage each time a cell might be debased.
An evolutionary geneticist at the University of Chicago in Illinois and an author of the study, Vincent Lynch stated that what they found in elephants is that there is an additional copy of the gene whose activity is to execute the cell when there is the sort of stress that has the potential to cause cancer. The way that this quality was even useful was remarkable―it should be non-utilitarian or “dead”. However by one means or another this “zombie” quality, called LIF6 (leukemia inhibitory factor 6), had advanced in elephants to resurrect and kill any cell that demonstrated harm to its DNA, in this manner keeping it from getting to be dangerous. This is the second investigation that has discovered the distinctions in elephant genome that may disclose the creature’s capacity to oppose the ailment.
In 2015, two groups of researchers―one driven by the University of Utah and the other by the Lynch from the University of Chicago―found in elephants 20 duplicates of a noteworthy disease smothering quality called p53 that enables harmed cells to repair themselves or self-destruct when presented to malignancy causing cancer.